Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
The Brazilian government recently reached an agreement with the producers of the HIV/AIDS drug Kaletra to reduce its price by 29.5 per cent. Following the deal, Thailand has also demanded higher cuts than those in Brazil from the drug's producers Abbott Laboratories Inc. The cost per patient per year for …
Brazil recently issued a compulsory licence that will allow the manufacture of generic versions of a drug, which is used to treat hiv/aids patients. The drug, Sustiva (efavirenz), is marketed as Stocrin by Merck and Co in developing nations. The licence will allow generic versions in spite of Merck's patent …
cell phone Ban: In a ruling on May 7, 2007, the Supreme Court of the State of New York supported the department of education's (DOE's) ban on the use of cell phones in schools. Eight parents had sued the city calling the ban "irrational and unsafe'. They claimed it intruded …
The multinational pharmaceutical corporation Abbott Laboratories announced a significant cut in the cost of its life-saving drug Kaletra (a protease inhibitor to treat hiv/aids) in 40 developing countries including India. Abbott claims the new price is lower than that offered by any generic manufacturer of the drug, and is 55 …
That health care facilities available to the poor are insufficient is common knowledge. According to a recent report of the Associated Chamber of Commerce and Industry of India (assocham), 1,083 family welfare centres fail to provide health care to the 180 million urban poor, with the shortfall being more for …
Anaemia is a widespread condition in India. The biggest cause is malnourishment and iron-poor diets. Though the best remedy is a good diet, anaemia has spawned a huge market for iron supplements, usually of the expensive variety (see box: Market slice). A 2006 market survey by the Drug Action Forum-Karnataka …
Indian drug manufacturer Ranbaxy is contesting us multinational Pfizer in 17 countries. It is filing for the right to manufacture generic versions of the world's bestselling drug Lipitor and a combination drug Caduet, in the us. But it hasn't really struck a blow for the generic pharma industry: Ranbaxy remains …
The Ranbaxy-Pfizer dispute involves three drugs:Lipitor, Caduet and Norvasc. The last named is a blood pressure drug. Pfizer's patent over it was annulled recently ending a lucrative monopoly: Norvasc, Pfizer's second biggest selling drug, earned the company about US$5 billion in sales in 2006. But the company combined one of …
Alang's woes On March 12, 2007, the Supreme Court adjourned the hearing of a case against the Norwegian asbestos-laden ship Blue Lady for another six weeks. On March 8, an intervening petition was filed in the ongoing case by sarpanchs from 12 villages around the Alang-Sosiya shipbreaking yard. They argued …
thailand's capital Bangkok witnessed protests outside the office of us multinational Abbott Laboratories on March 14, 2007. A day before, the company had withdrawn applications to register seven new formulations including a new version of the anti-hiv-drug Kaletra. It claimed the Thai government had violated international patent laws by permitting …
on february 28, 2007, the us department of agriculture (usda) gave preliminary draft approval to a biotech company to plant genetically modified rice to produce human proteins, amidst fears about its risk to human health. If the project, proposed by California-based Ventria Biosciences, gets final approval it will be the …
The Indian Council of Medical Research (icmr) has recently purchased access rights to contents published in the uk-based Cochrane library's website. It contains evidence to assist decision-making related to healthcare, including reviews, clinical trials and results of research worldwide. The contract is for three years and the database is available …
the report of the Technical Expert Group headed by R A Mashelkar, set up to report on aspects of the patent law in the context of the international regime of intellectual property rights, has been withdrawn. The report was to have been used in a case filed by multinational pharmaceutical …
villagers of Paonta Sahib tehsil in Himachal Pradesh have accused pharmaceutical giant Ranbaxy of not complying with an order of the Himachal Pradesh High Court passed on July 27, 2006, staying its expansion plans. In January 2007, villagers approached the state pollution control board (pcb) seeking details of the plant's …
Angering global drug giants, Thailand's interim regime decided to issue more compulsory licences for import and production of generic HIV/AIDS drugs on February 12, 2007. The rising cost of AIDS treatment was cited as the reason. This will allow domestic firms to produce generic versions of drugs. The first licence …
Andhra Pradesh chief minister Y S Rajasekhara Reddy has said that the state government was developing the third phase of Genome Valley in Hyderabad over an area of 120 hectares. A biotech incubation centre would be set up and be supported with technical inputs from the Indian Institute of Chemical …
